Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Renalytix ( (RNLXY) ) is now available.
Renalytix plc announced it will transition back to filing as a foreign private issuer (FPI) with the Securities and Exchange Commission effective January 1, 2025. The company had been filing as a domestic reporting company since July 1, 2023 but determined it qualified as an FPI as of December 31, 2024, adhering to the guidelines set by the Securities Act of 1933.
More about Renalytix
YTD Price Performance: 23.81%
Average Trading Volume: 80,480
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $48.6M
See more insights into RNLXY stock on TipRanks’ Stock Analysis page.